• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alivus Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75599.0
  • ISIN : INE03Q201024
1,000.60 -30 (-2.96%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    991.90

  • Today’s High

    1,026.80

  • Open

    1,026.80

  • Perv Close

    1,031.10

  • 52W Low

    850.00

  • 52W High

    1,335.10

Key Indicators

  • P/E(TTM)

    25.28

  • Mar.Cap (₹Cr.)

    12,270.27

  • Div & Yield %

    0.50

  • Book Value(₹)

    229.75

  • Debt-Equity Ratio

    -2.96

  • AGM Date

    01-Aug-2025

  • EPS

    39.60

  • P/E Ratio

    25.28

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    12,270.27

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    24.53

  • BV (₹)

    229.70

  • Sales( ₹ in Cr.)

    2,386.88

  • NP (in Cr.)

    485.63

  • NP Var(%)

    3.0

  • Div%

    250.0

  • CPS (₹)

    44.50

  • EPS (₹)

    39.60

  • Traded Value (₹ in Lakhs)

    12,278.24

  • 52 Week High

    1,335.10

  • 52 Week Low

    850.00

  • Price BSE

    1001.0

  • Price NSE

    1,001.00

  • Market Capital( in Cr.)

    12,278.24

  • P/C Ratio

    22.50

  • P/E Ratio

    25.30

  • Price Vs.BV

    39.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2,283.21 2,161.22 2,123.21 1,885.17 1,537.31 886.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,283.21 2,161.22 2,123.21 1,885.17 1,537.31 886.42
Other Income 12.04 28.96 14.70 0.81 11.99 0.44
Stock Adjustments 56.57 84.44 -41.32 70.70 4.64 301.59
Total Income 2,351.82 2,274.62 2,096.59 1,956.68 1,553.94 1,188.45
EXPENDITURE :            
Raw Materials 1,025.21 1,068.56 977.96 948.17 668.66 633.56
Power and Fuel Cost 112.46 115.60 100.92 74.19 76.75 57.81
Employee Cost 258.16 180.18 168.72 149.13 142.28 106.28
Other Manufacturing Expenses 163.64 137.17 124.04 107.32 108.04 77.09
Selling and Administration Expenses 64.12 65.47 48.64 48.50 42.05 44.20
Miscellaneous Expenses 41.97 36.39 45.56 37.49 32.22 21.35
Employee Benefit Expenses 258.16 180.18 168.72 149.13 142.28 106.28
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,665.54 1,603.36 1,465.83 1,364.80 1,069.99 940.29
Operating Profit 686.29 671.25 630.76 591.89 483.96 248.17
Interest 1.55 0.55 27.96 87.55 33.52 0.61
Gross Profit 684.74 670.70 602.80 504.34 450.44 247.56
Depreciation 53.45 42.09 37.88 33.39 29.37 19.26
Profit Before Tax 631.29 628.61 564.92 470.95 421.07 228.30
Current Tax 152.21 150.61 137.63 112.75 98.54 25.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 8.19 11.04 8.57 6.62 9.43 6.81
Reported Net Profit 470.89 466.96 418.72 351.58 313.10 195.59
Extraordinary Items -0.53 -0.41 -0.55 -0.44 -0.91 -0.54
Adjusted Net Profit 471.42 467.37 419.27 352.02 314.01 196.13
Adjustment below Net Profit -5.46 -0.29 -19.50 -0.53 0.47 -108.02
P & L Balance brought forward 1,102.06 1,021.35 750.79 399.73 86.17 -1.41
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 275.69 385.96 128.65 0.00 0.00 0.00
P & L Balance carried down 1,291.80 1,102.06 1,021.35 750.79 399.73 86.17
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,125.00 2,100.00 1,050.00 0.00 0.00 0.00
Dividend Per Share(Rs) 22.50 42.00 21.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 38.43 38.11 34.17 358.76 1,597.44 997.92
Earnings Per Share(Adj)-Unit Curr 38.43 38.11 34.17 - - -
Book Value 190.35 174.51 167.66 768.11 2,049.45 449.62
Book Value(Adj)-Unit Curr 190.35 174.51 167.66 - - -

Shareholding Pattern

  • Promoter Group

    74.94%

  • Public Share Holding

    25.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 91,896,285 74.94 91,896,285 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 91,896,285 74.94 91,896,285 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,867,970 6.42 7,867,970 67
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 217,653 0.18 217,653 3
Mutual Funds / UTI 4,973,788 4.06 4,973,788 18
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,693,776 1.38 1,693,776 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 14,753,187 12.03 14,753,187 101
2] Non Institution
Bodies Corporate 2,106,332 1.72 2,106,332 889
Clearing Members 1,322 0.00 1,322 6
Directors of their Relatives 56,600 0.05 56,600 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 789,465 0.64 789,465 2,750
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 304,942 0.25 304,942 2,598
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 909,873 0.74 909,873 5
Individuals holding nominal share capital up to Rs. 1 lakh 11,765,293 9.59 11,765,293 132,139
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 45,849 0.04 45,849 8
Others 0 0.00 0 0
Sub Total 15,979,676 13.03 15,979,676 138,398
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 122,629,148 100.00 122,629,148 138,500

Company Background

Alivus Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alivus Life Sciences Ltd
  • BSE Code : 75599.0
  • ISIN : INE03Q201024

  • Incorporation Year

    2011

  • Registered Office

    Plot No. 170-172 Chandramouli
    Industrial Est.Mohol Bazarpeth, Solapur,
    Maharashtra-413213

  • Telephone

    91-2189-234456/234246

  • FAX

  • Chairman

    HIREN KARSANBHAI PATEL

  • Managing Director

    Yasir Yusufali Rawjee

  • Company Secretary

    Rudalf Corriea

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Alivus Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alivus Life 1,001.25 2,295.26 2,283.21 25.28 27.94
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10